<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>The Nevada National Board Professional Learning Institute | Hogan | Activity</title>
	<link>http://www.nationalboardinstitute.com/members/egyptdew25/activity/</link>
	<atom:link href="http://www.nationalboardinstitute.com/members/egyptdew25/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Hogan.</description>
	<lastBuildDate>Fri, 23 May 2025 17:06:54 -0700</lastBuildDate>
	<generator>https://buddypress.org/?v=9.1.1</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">80d288f2a3b53000ca7002e85ada6438</guid>
				<title>Hogan posted an update: Results When groups were compared, interleukin - 2 was found [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/42102/</link>
				<pubDate>Sat, 08 Feb 2025 12:10:39 -0800</pubDate>

									<content:encoded><![CDATA[<p>Results When groups were compared, interleukin &#8211; 2 was found higher, whereas interleukin &#8211; 4 and interleukin &#8211; 10 were found lower in the SCI group at all collection times in the three exercise intensities (all P  less then  0.05). Interleukin &#8211; 1 receptor antagonist was found higher immediately after exercise at VT1, 15% above VT1 and 30 &hellip;<span class="activity-read-more" id="activity-read-more-42102"><a href="http://www.nationalboardinstitute.com/activity/p/42102/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">13dc2dc72effc30632579e6bbefe9eb4</guid>
				<title>Hogan posted an update: 9% and a specificity of 87.5%. CONCLUSION A short LVAT [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/40410/</link>
				<pubDate>Thu, 06 Feb 2025 16:15:07 -0800</pubDate>

									<content:encoded><![CDATA[<p>9% and a specificity of 87.5%. CONCLUSION A short LVAT indicated favorable mechanical synchrony in SPECT imaging. LVAT  less then  76&nbsp;ms might be a practical parameter for defining LBB capture.BACKGROUND Surgical treatment of lesions involving the ventral craniovertebral junction (CVJ) and the lower clivus, traditionally involved complex lat&hellip;<span class="activity-read-more" id="activity-read-more-40410"><a href="http://www.nationalboardinstitute.com/activity/p/40410/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">789add75c85d7136ea56a4ccc5bc82ad</guid>
				<title>Hogan posted an update: Selective attention focuses visual processing on relevant [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/38660/</link>
				<pubDate>Tue, 04 Feb 2025 12:17:09 -0800</pubDate>

									<content:encoded><![CDATA[<p>Selective attention focuses visual processing on relevant stimuli in order to allow for adaptive behaviour despite an abundance of distracting information. It has been proposed that increases in alpha band (8-12 ​Hz) amplitude reflect an active mechanism for distractor suppression. If this were the case, increases in alpha band amplitude should b&hellip;<span class="activity-read-more" id="activity-read-more-38660"><a href="http://www.nationalboardinstitute.com/activity/p/38660/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">295ca813d43f7d2c628e24e33f260f6e</guid>
				<title>Hogan posted an update: However, evidence for construct and convergent validity was [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/36672/</link>
				<pubDate>Sun, 02 Feb 2025 11:36:15 -0800</pubDate>

									<content:encoded><![CDATA[<p>However, evidence for construct and convergent validity was mixed. CONCLUSIONS Overall the 3-dimensional Malay MAIA was demonstrated to be both internally consistent and invariant across sex, but further evidence of construct and convergent validity is required. Issues that affect the dimensionality of MAIA scores in the present and extant work&hellip;<span class="activity-read-more" id="activity-read-more-36672"><a href="http://www.nationalboardinstitute.com/activity/p/36672/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">fb629cd97dd8f7d5ccb913223f930059</guid>
				<title>Hogan posted an update: r renal function - between CKD stage and adherence driven [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/34894/</link>
				<pubDate>Fri, 31 Jan 2025 12:00:59 -0800</pubDate>

									<content:encoded><![CDATA[<p>r renal function &#8211; between CKD stage and adherence driven BMD change. There were no cases of acute renal injury resulting in hospital encounters. More data is needed on the efficacy and safety of bisphosphonates in CKD stage 3B to 5 and prescribers should reconsider the low use of DXA in patients with renal function impairment now that a wider&hellip;<span class="activity-read-more" id="activity-read-more-34894"><a href="http://www.nationalboardinstitute.com/activity/p/34894/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">6f1b36b744014f00764be7d5724058a1</guid>
				<title>Hogan became a registered member</title>
				<link>http://www.nationalboardinstitute.com/activity/p/30944/</link>
				<pubDate>Tue, 28 Jan 2025 15:58:16 -0800</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>